ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag drug resistance microbiology disease medicine

New Strategies in the Battle Against Infectious Diseases
New Strategies in the Battle Against Infectious Diseases
The Scientist Staff | Jan 8, 2024 | 2 min read
Learn how the latest research into viral and bacterial pathogens advances the prevention and treatment of infectious diseases. 
Haydeh Payami is wearing a purple dress and an orange and pink scarf and standing in front of a whiteboard.
A Microbial Link to Parkinson’s Disease
Mariella Bodemeier Loayza Careaga, PhD | Dec 4, 2023 | 6 min read
Haydeh Payami helped uncover the genetic basis of Parkinson’s disease. Now, she hopes to find new ways to treat the disease by studying the gut microbiome.
bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
<style type="text/css" >p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 13.8px Helvetica; color: #000000}</style>Purple cartoon of candida auris with lines pointing places the bacteria clings to in a hospital, like a wheelchair, bed, skin, and catheter.&nbsp;
Seeking Solutions for a Sticky Situation
Danielle Gerhard, PhD | Mar 1, 2024 | 2 min read
To cling to everything from catheters to skin, Candida auris uses a unique approach.
Beating Drug-Resistant TB
Ruth Williams | Sep 19, 2012 | 3 min read
Reinvestigating a natural antibiotic compound reveals its potential as a tuberculosis drug.
Vet giving vaccines to pigs
Antimicrobial Resistance: The Silent Pandemic
Danielle Gerhard, PhD | Jun 30, 2023 | 9 min read
Scientists continue to ring alarm bells about the risks associated with the continued misuse of antimicrobials and advocate for innovative treatments, improved surveillance, and greater public health education.
Companies Seeking Solutions To Emerging Drug Resistance
Stephen Hoffert | Apr 12, 1998 | 10 min read
PHASE III NEARS: Cubist Pharmaceuticals has a promising antibiotic--daptomycin--that the company hopes to have in Phase III clinical trials in late 1998 or early 1999. Bacteria are back. Following the discovery and introduction into medicine of penicillin in 1941, intense research in microbiology produced a potent armament of antibiotics that all but eliminated a variety of infectious diseases. With this success, many large pharmaceutical companies scaled back research and development of new
Interfering with Resistance
Hannah Waters | Jun 1, 2012 | 2 min read
Drug efficacy and resistance mechanisms shine a light on how drugs enter cells, which could facilitate the development of new sleeping-sickness treatments. 
A needle drawing up fluid from an unlabeled vial.
Cancer Vaccination as a Promising New Treatment Against Tumors
Shelby Bradford, PhD | Mar 15, 2024 | 10+ min read
Vaccination has beaten back infections for more than a century. Now, it may be the next big step in battling cancer.
Doctors’ Advice to Finish Antibiotics Overlooks Resistance
Abby Olena, PhD | Aug 11, 2017 | 4 min read
There is little evidence that full treatment durations discourage the development of drug-resistant bacteria.

Run a Search

ADVERTISEMENT